Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Description

This mixed methods study evaluates the effectiveness and feasibility of a multi-level (patient, team, organizations) intervention to optimize CRC screening for patients with diabetes in primary care safety-net settings.

Conditions

Colorectal Cancer Screening, Diabetes Mellitus, Type 2

Talk to us

Study Overview

On this page

Study Details

Study overview

This mixed methods study evaluates the effectiveness and feasibility of a multi-level (patient, team, organizations) intervention to optimize CRC screening for patients with diabetes in primary care safety-net settings.

Optimizing Colorectal Cancer Screening Among Patients With Diabetes in Safety-Net Primary Care Settings: Targeting Implementation Approaches

Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Condition
Colorectal Cancer Screening
Intervention / Treatment

-

Contacts and Locations

New Brunswick

RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States, 08903

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of diabetes mellitus;
  • * Participants not up-to-date with CRC screening based on electronic health record (e.g. FOBT/FIT in last year; flexible sigmoidoscopy within four years; or colonoscopy within nine years);
  • * Age-eligible for CRC screening (50-74 years of age);
  • * Participants in process of undergoing screening are eligible for participation if they have a FIT/FOBT incomplete test ordered for more than six months or a sigmoidoscopy or colonoscopy referral not completed for greater than one year.

Ages Eligible for Study

50 Years to 74 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Rutgers, The State University of New Jersey,

Denalee O'Malley, PhD, PRINCIPAL_INVESTIGATOR, Rutgers Robert Wood Johnson Medical School; Rutgers Cancer Institute of New Jersey

Study Record Dates

2025-09-30